
Zixi Gets Strategic Investment From Clearhaven Partners The software supplier aims to be tech partner of choice for IP-based media transport globally By Ken Kerschbaumer, Editorial Director
Thursday, June 13, 2024 - 9:48 am
Print This Story | Subscribe
Story Highlights
Zixi, provider of the award-winning Software-Defined Video Platform (SDVP) and provider of scalable and cost-efficient live-video transport over any Internet Protocol network, has received a significant investment from Boston-based software private-equity firm Clearhaven Partners to drive the next stages of growth.
Most users deployed Zixi-as-a-Service in 2023, when recurring revenue from OTT customers grew 100% from the previous year.
Partnering with Clearhaven, an investor group with a great deal of expertise scaling software companies and with a unique video thesis, is a natural fit for Zixi and one that will enable us to double down on product innovation, set the highest standards for serving our valued, worldwide customer base, and ensure our business achieves next-level scale and scalability, says Zixi CEO/Executive Chairman Gordon Brooks. As we enter our next stage of growth and innovation, we're delighted to partner with Clearhaven to pursue the significant opportunities in our market.
Clearhaven Partners is a Boston-based private-equity firm founded in 2019 to focus exclusively on enterprise and B2B-software investments. Clearhaven invests thematically, targeting companies like Zixi for their differentiated solutions in managing complex content and data flows in hybrid-infrastructure environments. The firm will work closely with Zixi to support its continued innovation, customer-focused culture, and scalability in achieving next-era growth and success. With Clearhaven's backing, Zixi will deliver on its mission to be the technology partner of choice for IP-based media transport in the global-market opportunity that has reached a critical inflection point for growth.
Industry analysts forecast IP-based video systems to reach $8 billion a year in the next decade, with a 30% CAGR as IP transport accelerates ahead of satellite-driven. In 2023, Zixi's annual recurring revenue from OTT customers grew 100% year over year, with most users deploying Zixi-as-a-Service (ZaaS).
Broadcasting customers grew more than 30%, and the SDVP was used to broadcast more than 1.5 million live sports events globally. This growth reflects Zixi's leading role in the industry's continued transformation and need for agile, cost-effective IP video workflows with best-in-class network visibility and orchestration.
Zixi is a trusted partner for consistent innovation, thought leadership, and commitment to customers' success as they scale. Zixi's platform monitors 9 billion mission-critical telemetry data points each day, driving powerful AI/ML-driven analytics, live predictive health scores, trends and insights, automated incident detection, and root-cause analysis for customers at a fraction of the cost of legacy manual methods.
Zixi is a bull's-eye fit for Clearhaven's investment, says Clearhaven Partners Founder/Managing Partner Michelle Noon. We have long admired Zixi's differentiated technology, unrivaled ecosystem integrations, and position as a trusted technology partner to discerning global technology and media companies. As important, we are pleased to partner with Gordon and the Zixi management team and to complement the innovation and brand strength of Zixi with our skills in efficiently scaling enterprise-software businesses in this exciting next chapter.
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
07/10/2026
Dalet, a leading technology and service provider for media-rich organizations, today announced the latest Long-Term Supported (LTS) release of Dalet Flex. Build...
06/09/2026
June 9 2026, 23:00 (PDT) Dolby and MagentaTV Bring Fans Closer to the FIFA Worl...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
At IBC2026, MediaKind will make its first major appearance as a unified global powerhouse in video, showcasing one of the world's most comprehensive video i...
06/08/2026
Big Blue Marble (#5.A63) will demonstrate how its integrated technology and operational expertise help media companies scale premium services with less complexi...
06/08/2026
LA JOLLA, CA-Scripps Research has received more than $500,000 in first-year fund...
06/08/2026
LA JOLLA, CA-Viruses are masters at invading our cells thanks to specialized proteins that coat their surfaces. When scientists design vaccines, they often crea...
06/08/2026
LA JOLLA, CA-The brain has its own immune system, which detects threats and mounts a defense. A growing body of evidence has shown that in Alzheimer's disea...
06/08/2026
LA JOLLA, CA-Scripps Research chemist Jin-Quan Yu has been elected to the National Academy of Sciences (NAS), one of the highest honors a scientist can achieve....
06/08/2026
LA JOLLA, CA-Scripps Research ranked third in the inaugural 2026 Cure Innovation Index recognizing the top-performing institutes and centers across the United S...
06/08/2026
Benjamin Cravatt, the Gilula Chair of Chemical Biology and a professor of chemis...
06/08/2026
LA JOLLA, CA-Dennis Burton, professor and the James & Jessie Minor Chair in Immu...
06/08/2026
LA JOLLA, CA-Inside every human cell, proteins are constantly being tagged with small chemical modifications after they're produced. Known as post-translati...
06/08/2026
LA JOLLA-Scripps Research has established the Ian Wilson Endowed Chair, a new fa...
06/08/2026
Scripps Research's Skaggs Graduate School of Chemical and Biological Science...
06/08/2026
LA JOLLA, CA-Professor Jin-Quan Yu of Scripps Research has been elected to the Fellowship of the Royal Society, the U.K.'s national academy of sciences and ...
06/08/2026
LA JOLLA, CA-For years, researchers have been hoping for vaccines that protect people against not just one strain of HIV, but every strain of the quickly mutati...
06/08/2026
LA JOLLA, CA-The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit...
06/08/2026
LA JOLLA, CA-Building the complex 3D molecules needed for new medicines has alwa...
06/08/2026
LA JOLLA, CA-Fentanyl and related variants of the synthetic opioid kill more Americans each year than car accidents and gun violence combined. In too-high doses...
06/08/2026
LA JOLLA, CA-What do decoding communication between organs and reimagining the future of genome editing have in common? They're among the scientific questio...
06/08/2026
LA JOLLA, CA-Of the 1.2 million people living with HIV in the United States, app...
06/08/2026
LA JOLLA, CA-For some people, cancer immunotherapies are life-changing. These treatments can turn the body's own immune system against a tumor, either elimi...
06/08/2026
LA JOLLA, CA-Many conditions that cause vision loss share a common feature: the ...
06/08/2026
LA JOLLA, CA-RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.
Crowned with the 2006 Nobel Priz...
06/08/2026
LA JOLLA, CA-The drugs that keep rheumatoid arthritis in check may one day help people stop drinking. A new Scripps Research study shows that an anti-inflammato...
06/08/2026
LA JOLLA, CA-Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide in 2019 alone. As mor...
06/08/2026
LA JOLLA, CA-Some of the world's best-selling diabetes drugs depend on a che...
06/08/2026
LA JOLLA, CA-Detecting infectious disease threats early and responding quickly can dramatically alter the course of an infectious outbreak. Technologies such as...
06/08/2026
LA JOLLA, CA-Molecular biophysicist Joan Pulupa will join Scripps Research in Ja...
06/08/2026
LA JOLLA, CA-HIV is globally so diverse, consisting of hundreds of thousands of ...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
At this year's SET EXPO, PlayBox Neo will present recent innovations across its PlayBox Neo Suite and integrated range of broadcast media solutions. By show...
06/08/2026
Live demo at IBC2026 VisualOn Booth, Hall 5, Stand A55
Amsterdam, Netherlands Modern Streaming Solutions Private Limited, a rising force in India's dig...
06/08/2026
Screen Australia and YouTube Australia fund five new teams through eleventh Skip...
06/08/2026
How Karukera Studio Built a Media Production Hub with SNS EVO
Melanie Ciotti August 5, 2026
0 Comments
Hero images displays Karukera Studio in Sainte-...
06/08/2026
NHK drama series Rosanjin no Kamado shot on PYXIS 6K
Brie Clayton August 5, 2026
0 Comments
Blackmagic PYXIS 6K and DaVinci Resolve Studio capture the...
06/08/2026
Camera Match: AutoSetup 3d Plugin / script for Photomontages- Cinema 4D
Jamie Cardoso August 5, 2026
0 Comments
If you do any kind of Architectural Vi...
06/08/2026
In Time airs Monday 10 August at 9.35pm on RT One and RT Player
In Time is the first film account of the life of D nal Lunny, one of the most influential Iri...
06/08/2026
Editor's note: This post is part of Into the Omniverse, a series focused on how developers, 3D practitioners and enterprises can transform their workflows u...
06/08/2026
August is here, bringing 26 new games for GeForce NOW members.
Command the seas in World of Warships: Legends and discover what's next in the GeForce NOW ...
05/08/2026
Thomson's Climate Crisis Toolkit for Media in Tanzania is being included in a new virtual library designed to ensure accurate and engaging storytelling arou...
05/08/2026
RSNs, teams, leagues, and streamers explore the present and future of local spor...
05/08/2026
As sports-production workflows generate larger volumes of unstructured data and ...